Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

SOS Regulation of qnrB Expression

Minghua Wang, George A. Jacoby, Debra M. Mills, David C. Hooper
Minghua Wang
1Massachusetts General Hospital, Boston, Massachusetts
2Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George A. Jacoby
3Lahey Clinic, Burlington, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: george.a.jacoby@lahey.org
Debra M. Mills
3Lahey Clinic, Burlington, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Hooper
1Massachusetts General Hospital, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00132-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In the sequence upstream from qnrB (but not qnrA or qnrS) is a LexA binding site. qnrB was shown to be under SOS control by demonstrating that quinolone susceptibility decreased with increasing temperature in a strain with a recA441(Ts) allele, whereas qnrB expression increased in response to ciprofloxacin or mitomycin C in strains with an intact lexA gene.

Plasmid-mediated Qnr proteins provide low-level quinolone resistance and protect bacterial DNA gyrase and topoisomerase IV from quinolone inhibition (21, 22). QnrA, QnrB, and QnrS are currently known (7, 10, 14). All are pentapeptide repeat proteins differing from each other by 40% or more in amino acid sequence, while within each type minor variations in sequence define alleles such as QnrB1 and QnrB2 (18). In addition to protecting DNA gyrase, QnrB1 (but not QnrA1) at high concentrations has been shown to inhibit the enzyme in vitro, which may explain the bacterial growth inhibition observed when the gene is maximally expressed (10). We have discovered that qnrB is regulated by the SOS system so that quinolone exposure augments its expression.

Table 1 shows the DNA sequences at the starts of the qnr genes. Two in-phase ATG start codons are present in qnrB1, qnrB3, and qnrB5. In qnrB2 and qnrB4 the first ATG is out of phase with the remainder of the reading frame, suggesting that for all five alleles translation may be initiated at the second ATG codon. Between the two start codons is a LexA binding site or box, the canonical sequence of which is TACTGTATATATATACAGTA with the 5′-CTGT essential and the central (AT)4 known to vary in different LexA boxes (4, 23). No LexA binding site was found upstream from qnrA1 or qnrS1. A similar LexA box, however, is found upstream from all those qnrB alleles in GenBank for which this region of the sequence has been reported, including qnrB6, qnrB10, qnrB12, qnrB13, qnrB14, qnrB15, qnrB16, qnrB17, and qnrB18 (8).

To determine whether expression of qnrB alleles is under SOS control, plasmids were introduced into Escherichia coli GW1000 (11) with recA441, which encodes a RecA protease that is more easily activated, so that the strain would be SOS inducible at 30°C but constitutive at 42°C, and into E. coli J53 azider (9), which has wild-type lexA and recA alleles. qnrB1 plasmid pMG298 (10), qnrB2 plasmid pMG301 (10), qnrB3 plasmid pMG317 (19), qnrB4 plasmid pMG319 (19), qnrB5 plasmid pMG305 (6), and qnrA1 plasmid pMG252 (14) (all natural plasmids) were introduced by conjugation. Tra−qnrS1 plasmid pMG306 (6) was introduced into GW1000 by transformation.

As shown in Table 2 GW1000 derivatives containing plasmids with qnrB alleles demonstrated two- to eightfold decreases in ciprofloxacin susceptibility as the growth temperature increased. R− GW1000 also showed a decrease in susceptibility with rising temperature, but the decrease was less than that observed in qnrB derivatives. A two- to threefold decrease in susceptibility was also seen in strains with plasmids carrying qnrA1 or qnrS1 alleles. In E. coli J53 with unmodified SOS regulation, temperature had only a twofold effect on the level of qnrB1-mediated ciprofloxacin resistance.

While the trend observed suggested that qnrB alleles are specifically regulated by the SOS system, the MIC results were not clear-cut because of a background effect of temperature on quinolone susceptibility. To document SOS regulation directly, the expression of qnr genes was measured by real-time quantitative PCR after a 15- to 30-min exposure to agents known to trigger the SOS response. Strains were grown in LB broth at 37°C to exponential phase in triplicate. When the optical density at 600 nm reached 0.08 to 0.1, 0.1 μg/ml ciprofloxacin or 0.2 μg/ml mitomycin C was added, leaving one culture as a control. Aliquots (200 to 300 μl) were treated with RNAprotect bacteria reagent (Qiagen, Valencia, CA) and centrifuged, the pellet was briefly frozen and treated with lysozyme, and the RNA was extracted with an RNeasy Mini kit (Qiagen) and treated with Turbo DNA-free (Ambion, Austin, TX). cDNA synthesis was performed with a Verso reverse transcription-PCR kit (Abgene, Epsom, United Kingdom) using gene-specific reverse primers (Table 3). Quantitative PCR amplification was conducted in an MJ Research PTC-200 thermal cycler with a Chromo4 detector (Bio-Rad, Hercules, CA) using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and the listed primers (Table 3). The housekeeping mdh (malate dehydrogenase) gene was used as an internal control and did not change in response to the inducing agents. Experiments were repeated at least twice. RNA transcript levels were calculated using the 2−ΔΔCT method (12), where CT is the cycle number of the detection threshold, and are expressed relative to levels in the unsupplemented control.

Table 4 shows that in E. coli J53 with intact lexA and recA genes expression of qnrB alleles increased between 2.1- and 9.9-fold in response to the inducing agents while expression of qnrA1 was unchanged. Proof that this increase in qnrB expression required an intact SOS system was obtained with a set of related strains. Expression of qnrB4 increased in response to ciprofloxacin or mitomycin C in E. coli AB1157 with wild-type lexA and recA genes but not in two strains derived from it: strain AB1157 LexA300::spec, which has a defective LexA protein so that LexA-regulated genes are constitutively expressed, or strain DM49 (15), which has a protease-resistant LexA product and consequently is defective in SOS induction.

The SOS response is triggered by DNA damage, such as that generated by quinolones (13, 24). The RecA protein is activated by single-stranded DNA and acts as a coprotease to cleave the LexA protein, which otherwise binds as a dimer to LexA boxes, repressing expression of adjacent genes. More than 40 genes or operators on the chromosome of E. coli are so regulated (4, 5). Most are involved in DNA repair or regulation of cell division. The native function of qnr genes is not known. They have been found on the chromosome of both gram-negative and gram-positive bacteria (1, 2, 16, 17, 20). SOS regulation of QnrB could be a carryover reflecting a role for this topoisomerase-interacting protein in response to DNA damage. Alternatively, SOS regulation serves to protect the host cell from the potentially toxic effects of QnrB while allowing augmented production upon exposure to quinolone antimicrobial agents. Since the SOS response also results in derepression of specialized DNA polymerases that promote quinolone resistance by mutations (3), it thus coordinates both qnrB plasmid-mediated and chromosomal target-derived resistance.

View this table:
  • View inline
  • View popup
TABLE 1.

Nucleotide sequences at the starts of plasmid-mediated qnrB, qnrA, and qnrS alleles

View this table:
  • View inline
  • View popup
TABLE 2.

Quinolone susceptibility as a function of temperature in strains with varying SOS response regulation

View this table:
  • View inline
  • View popup
TABLE 3.

Primers used for RT-PCR

View this table:
  • View inline
  • View popup
TABLE 4.

Expression of qnr alleles

ACKNOWLEDGMENTS

We thank Jamie Foti and Graham Walker for providing E. coli DM49, GW1000, and AB1157 LexA300::spec and the E. coli Genetic Resource Center for E. coli AB1157.

M.W. was supported by the China Scholarship Council and grant no. 2005CB0523101 from the National Basic Research Program of China from the Ministry of Science and Technology. The work was also supported by grants AI43312 (G.A.J.) and AI57576 (D.C.H.) from the National Institutes of Health, U.S. Public Health Service.

FOOTNOTES

    • Received 30 January 2008.
    • Returned for modification 3 April 2008.
    • Accepted 12 November 2008.
  • Copyright © 2009 American Society for Microbiology

REFERENCES

  1. 1.↵
    Arsène, S., and R. Leclercq. 2007. Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob. Agents Chemother.51:3254-3258.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Cattoir, V., L. Poirel, D. Mazel, C.-J. Soussy, and P. Nordmann. 2007. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob. Agents Chemother.51:2650-2651.
    OpenUrlFREE Full Text
  3. 3.↵
    Cirz, R. T., and F. E. Romesberg. 2006. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob. Agents Chemother.50:220-225.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Courcelle, J., A. Khodursky, B. Peter, P. O. Brown, and P. C. Hanawalt. 2001. Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics158:41-64.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Fernandez De Henestrosa, A. R., T. Ogi, S. Aoyagi, D. Chafin, J. J. Hayes, H. Ohmori, and R. Woodgate. 2000. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol. Microbiol.35:1560-1572.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Gay, K., A. Robicsek, J. Strahilevitz, C. H. Park, G. Jacoby, T. J. Barrett, F. Medalla, T. M. Chiller, and D. C. Hooper. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis.43:297-304.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother.49:801-803.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Jacoby, G., V. Cattoir, D. Hooper, L. Martínez-Martínez, P. Nordmann, A. Pascual, L. Poirel, and M. Wang. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother.52:2297-2299.
    OpenUrlFREE Full Text
  9. 9.↵
    Jacoby, G. A., and P. Han. 1996. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol.34:908-911.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother.50:1178-1182.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Kenyon, C. J., and G. C. Walker. 1980. DNA-damaging agents stimulate gene expression at specific loci in Escherichia coli. Proc. Natl. Acad. Sci. USA77:2819-2823.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods25:402-408.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Malik, M., X. Zhao, and K. Drlica. 2006. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones. Mol. Microbiol.61:810-825.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet351:797-799.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Mount, D. W., K. B. Low, and S. J. Edminston. 1972. Dominant mutations (lex) in Escherichia coli K-12 which affect radiation sensitivity and frequency of ultraviolet light-induced mutations. J. Bacteriol.112:886-893.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Poirel, L., A. Liard, J. M. Rodriguez-Martinez, and P. Nordmann. 2005. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J. Antimicrob. Chemother.56:1118-1121.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Poirel, L., J. M. Rodriguez-Martinez, H. Mammeri, A. Liard, and P. Nordmann. 2005. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother.49:3523-3525.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis.6:629-640.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother.50:2872-2874.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Rodríguez-Martínez, J. M., C. Velasco, A. Briales, I. García, M. C. Conejo, and A. Pascual. 2008. Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J. Antimicrob. Chemother.61:1240-1243.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA99:5638-5642.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Tran, J. H., G. A. Jacoby, and D. C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother.49:3050-3052.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Walker, G. C. 1984. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol. Rev.48:60-93.
    OpenUrlFREE Full Text
  24. 24.↵
    Ysern, P., B. Clerch, M. Castano, I. Gibert, J. Barbe, and M. Llagostera. 1990. Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis5:63-66.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
SOS Regulation of qnrB Expression
Minghua Wang, George A. Jacoby, Debra M. Mills, David C. Hooper
Antimicrobial Agents and Chemotherapy Jan 2009, 53 (2) 821-823; DOI: 10.1128/AAC.00132-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SOS Regulation of qnrB Expression
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SOS Regulation of qnrB Expression
Minghua Wang, George A. Jacoby, Debra M. Mills, David C. Hooper
Antimicrobial Agents and Chemotherapy Jan 2009, 53 (2) 821-823; DOI: 10.1128/AAC.00132-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Drug Resistance, Bacterial
Escherichia coli Proteins
gene expression
quinolones
SOS Response (Genetics)

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596